Custom Search:

WCG FDAnews Announces: The Return of VALID Webinar on May 17, 2023

The pandemic has resulted in increased scrutiny from policymakers and patient advocacy groups on FDA regulatory policy for vaccines, diagnostic testing, particularly lab-developed tests (LDT), and in vitro diagnostics (IVD).

Image of Georgio Salas By Georgio Salas.
Updated May 10, 2023

FALLS CHURCH, Va. (PRWEB) May 10, 2023 - In this webinar, medical device manufacturers will be updated on the current IVD and LDT regulatory landscape and potential implications of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act).

Michael M. Gaba, FDA Practice vice chair, Colleen Faddick, Health Care Operations Practice chair, and Christopher C. Rorick, senior policy advisor from the Public Policy Practice Group at Polsinelli, will explain why there is significant interest in further regulating these diagnostic mechanisms beyond what the FDA currently has in place via the Clinical Laboratory Improvement Amendments (CLIA) and medical device policy, and the implications for ensuring adequate clinical validation if the VALID Act becomes law.

Webinar attendees will:

Webinar Details The Return of VALID: What the Future Holds for IVDs and LDTs An FDAnews Webinar Wednesday, May 17, 2023, 1:30 p.m.-3:00 p.m. EDT https://wcg.swoogo.com/the-return-of-valid

Tuition: $287

Easy Ways to Order: Online: https://wcg.swoogo.com/the-return-of-valid By phone: 888.838.5578 or 703.538.7600

About WCG FDAnews: WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on WCG FDAnews' newsletters, books, databases, webinars and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations. Learn more at fdanews.com.